Breast cancer risk factors and age at diagnosis: An Icelandic cohort study

2002 ◽  
Vol 98 (4) ◽  
pp. 604-608 ◽  
Author(s):  
Laufey Tryggvadóttir ◽  
Hrafn Tulinius ◽  
Jórunn E. Eyfjord ◽  
Trausti Sigurvinsson
2015 ◽  
Vol 33 (28_suppl) ◽  
pp. 110-110
Author(s):  
Salome Arobelidze ◽  
Abdo S. Haddad ◽  
Timothy Peter Spiro ◽  
Hamed Daw

110 Background: We conducted a retrospective study to investigate male breast cancer risk factors, treatment and survival. Methods: All patients with male breast cancer diagnosed between 1985 and 2014 at the Cleveland Clinic were retrospectively reviewed. Results: 131 patients were enrolled in the study. The median age at diagnosis was 66. Most of the tumors were invasive ductal carcinomas (85%, 111/131) and most were intermediate grade (47%, 41/87). Most patients had localized disease – stage 0-1 (45%, 48/107); stage 2 (35%, 37/107). Among the patients with data, 93% (94/101) were ER+, 73% (74/101) were PR+, 12% (10/80) were HER2 positive, and 6% were triple negative. Estimated median survival was 20.2 years (95% C.I. 19.0-29.4), and estimated 2 and 5-year survival were 96% + 2% and 87% + 3%. Grade was associated with outcome (p=.07). Conclusions: In our study only age at diagnosis was associated with overall survival. Further research is required to understand the treatment outcomes of this rare cancer. [Table: see text]


2013 ◽  
Vol 88 (3) ◽  
pp. 165-170 ◽  
Author(s):  
Sulafa T. Al-Qutub ◽  
Rajaa M. Al-Raddadi ◽  
Bakr M. Bin Sadiq ◽  
Wafa Sait ◽  
Aboelkhair Al-Gahmi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document